BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 11953465)

  • 21. Molecular parameters for precise diagnosis of asymptomatic Epstein-Barr virus reactivation in healthy carriers.
    Maurmann S; Fricke L; Wagner HJ; Schlenke P; Hennig H; Steinhoff J; Jabs WJ
    J Clin Microbiol; 2003 Dec; 41(12):5419-28. PubMed ID: 14662920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr and cytomegalovirus DNA salivary shedding correlate with long-term plasma HIV RNA detection in HIV-infected men who have sex with men.
    Scaggiante R; Andreis S; Basso M; Franchin E; Franzetti M; Del Vecchio C; Torti C; Mengoli C; Cruciani M; Sarmati L; Palù G; Parisi SG
    J Med Virol; 2016 Jul; 88(7):1211-21. PubMed ID: 26636290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S; Ersoy A; Sevinir BB; Sınırtaş M; Göral G
    Mikrobiyol Bul; 2012 Oct; 46(4):594-606. PubMed ID: 23188573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of Epstein-Barr Virus Salivary Shedding in HIV/AIDS Patients and HAART Use: A Retrospective Cohort Study.
    Yan Y; Ren Y; Chen R; Hu J; Ji Y; Yang J; Shen J; Hu L; Pei H; Wang J; Qiu Y; Lu H; Huang L
    Virol Sin; 2018 Jun; 33(3):227-233. PubMed ID: 29654554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of automated DNA extraction coupled with real-time PCR for measuring Epstein-Barr virus load in whole blood, peripheral mononuclear cells and plasma.
    Fafi-Kremer S; Brengel-Pesce K; Barguès G; Bourgeat MJ; Genoulaz O; Seigneurin JM; Morand P
    J Clin Virol; 2004 Jun; 30(2):157-64. PubMed ID: 15125872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Epstein-Barr viral DNA in serum using rapid-cycle PCR.
    Mouritsen CL; Wittwer CT; Reed G; Khan TM; Martins TB; Jaskowski TD; Litwin CM; Hill HR
    Biochem Mol Med; 1997 Apr; 60(2):161-8. PubMed ID: 9169098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study.
    Westmoreland KD; Stanley CC; Montgomery ND; Kaimila B; Kasonkanji E; El-Mallawany NK; Wasswa P; Mtete I; Butia M; Itimu S; Chasela M; Mtunda M; Chikasema M; Makwakwa V; Kampani C; Dhungel BM; Sanders MK; Krysiak R; Tomoka T; Liomba NG; Dittmer DP; Fedoriw Y; Gopal S
    Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27781380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
    PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr viral load as a marker of lymphoma in AIDS patients.
    Fan H; Kim SC; Chima CO; Israel BF; Lawless KM; Eagan PA; Elmore S; Moore DT; Schichman SA; Swinnen LJ; Gulley ML
    J Med Virol; 2005 Jan; 75(1):59-69. PubMed ID: 15543571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of Epstein-Barr virus (HHV-4) and CMV (HHV-5) infection among subtype-C human immunodeficiency virus-infected individuals.
    Sachithanandham J; Kannangai R; Pulimood SA; Desai A; Abraham AM; Abraham OC; Ravi V; Samuel P; Sridharan G
    Indian J Med Microbiol; 2014; 32(3):261-9. PubMed ID: 25008818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
    J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus (EBV) replicative gene expression in tumour cells of AIDS-related non-Hodgkin's lymphoma in relation to CD4 cell number and antibody titres to EBV.
    Brousset P; Drouet E; Schlaifer D; Icart J; Payen C; Meggetto F; Marchou B; Massip P; Delsol G
    AIDS; 1994 May; 8(5):583-90. PubMed ID: 7914731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytomegalovirus, Epstein-Barr virus and human herpesvirus 8 salivary shedding in HIV positive men who have sex with men with controlled and uncontrolled plasma HIV viremia: a 24-month longitudinal study.
    Basso M; Andreis S; Scaggiante R; Franchin E; Zago D; Biasolo MA; Del Vecchio C; Mengoli C; Sarmati L; Andreoni M; Palù G; Parisi SG
    BMC Infect Dis; 2018 Dec; 18(1):683. PubMed ID: 30567494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Epstein-Barr Virus DNA Load and Antibodies Against EBNA1 and EA in Sardinian Patients with Rheumatoid Arthritis.
    Erre GL; Mameli G; Cossu D; Muzzeddu B; Piras C; Paccagnini D; Passiu G; Sechi LA
    Viral Immunol; 2015 Sep; 28(7):385-90. PubMed ID: 26083265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Burden of Epstein-Barr Virus (EBV) and Its Determinants among Adult HIV-Positive Individuals in Ethiopia.
    Zealiyas K; Teshome S; Berhe N; Amogne W; Haile AF; Abate E; Yimer G; Weigel C; Ahmed EH; Abebe T; Baiocchi R
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal and cross-sectional study ofEpstein-Barr virus DNA load: a possible predictor of AIDS-related lymphoma in HIV-infected patients.
    Hijlkema SH; van Kampen JJA; Voermans JJC; den Oudsten MYE; Doorduijn J; van Lugtenburg PJ; van de Vijver DAMC; van der Ende ME
    Infect Dis (Lond); 2018; 50(11-12):847-852. PubMed ID: 30317893
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.
    Panagiotakis SH; Soufla G; Baritaki S; Sourvinos G; Passam A; Zagoreos I; Stavrianeas N; Spandidos DA
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):10-8. PubMed ID: 17263627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.
    Richard Y; Amiel C; Jeantils V; Mestivier D; Portier A; Dhello G; Feuillard J; Creidy R; Nicolas JC; Raphael M
    J Infect Dis; 2010 Nov; 202(9):1424-34. PubMed ID: 20874514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.